CED Member BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) today announced that executives from BioCryst are scheduled to present and provide a corporate summary and update regarding the Company’s clinical programs at the following investor conferences:
- Cowen & Co. 32nd Annual Healthcare Conference in Boston, Massachusetts on Monday, March 5, 2012 at 4:50 p.m. Eastern time
- Roth Capital 24th Annual Growth Stock Conference in Dana Point, California on Wednesday, March 14, 2012 at 1:30 p.m. Pacific Time
Links to live audio webcasts and replays of both presentations may be accessed on the BioCryst website at www.BioCryst.com.
